Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF ANTI-IDIOPATHIC PULMONARY FIBROSIS DRUG NINTEDANIB IN TREATMENT OF TUBERCULOSIS
Document Type and Number:
WIPO Patent Application WO/2023/207398
Kind Code:
A1
Abstract:
Provided is use of nintedanib or a pharmaceutically acceptable salt thereof in preparing a drug for the treatment of tuberculosis. The nintedanib or the pharmaceutically acceptable salt thereof is used in combination with other anti-tuberculosis drugs for the treatment of tuberculosis, or used as an adjuvant drug for the treatment of tuberculosis, wherein the other anti-tuberculosis drugs are selected from: rifampicin, isoniazide, pyrazinamide, ethambutol, fluoroquinolone, streptomycin, kanamycin, amikacin, capreomycin, sodium aminosalicylate, ethionamide, cycloserine, clofazimine, and linezolid.

Inventors:
LU YU (CN)
CHEN XIAOYOU (CN)
QI XUETING (CN)
ZHENG LUYAO (CN)
FU LEI (CN)
ZHANG WEIYAN (CN)
WANG NING (CN)
Application Number:
PCT/CN2023/081772
Publication Date:
November 02, 2023
Filing Date:
March 16, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV (CN)
BEIJING TUBERCULOSIS CHEST CANCER INST (CN)
International Classes:
A61K31/4409; A61K31/496; A61K31/4965; A61K45/06; A61P11/00; A61P31/06
Domestic Patent References:
WO2017118584A12017-07-13
Foreign References:
CN114732818A2022-07-12
CN105902507A2016-08-31
CN107019697A2017-08-08
CN1857725A2006-11-08
Other References:
BATTAH BASEM, CHEMI GIULIA, BUTINI STEFANIA, CAMPIANI GIUSEPPE, BROGI SIMONE, DELOGU GIOVANNI, GEMMA SANDRA: "A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles", MOLECULES, vol. 24, no. 23, November 2019 (2019-11-01), pages 4373, XP093103677, DOI: 10.3390/molecules24234373
WANG, JIE: "Tuberculosis Treatment and Drug Progress", PHARMACEUTICAL AND CLINICAL RESEARCH, vol. 18, no. 5, 31 October 2010 (2010-10-31)
Attorney, Agent or Firm:
BEIJING HUAKE UNION PATENT OFFICE (CN)
Download PDF: